Suppr超能文献

竹茹提取物通过抑制mTORC1/SREBPs信号通路改善代谢相关脂肪性肝病的脂质蓄积。

Zhuru extracts ameliorate lipid accumulation of MASLD via suppressing the mTORC1/SREBPs pathway.

作者信息

Sun Zhaolin, Wei Yuhua, Ma Shuangyi, Xu Yuchen, Zhang Yuna, Li Changxian, Zhang Jinghan, Duan Feifei, Jiao Jianwei, Duan Xiuying

机构信息

School of Life Sciences, Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, China.

Department of Vascular Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, China.

出版信息

J Ethnopharmacol. 2025 Aug 29;352:120246. doi: 10.1016/j.jep.2025.120246. Epub 2025 Jul 3.

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent liver disease worldwide, primarily caused by poor lifestyle choices and dietary habits. Caulis Bambusae In Taenias, commonly known as Zhuru in Chinese, is a traditional Chinese medicinal material from the Bambusoideae family, frequently used for liver detoxification, liver protection, and lowering lipids.

AIM OF THE STUDY

The study aimed to reveal the protective effects and underlying mechanisms of Zhuru extracts (EZR) in treating MASLD.

METHODS

High performance liquid chromatography, liquid chromatography-tandem mass spectrometry, and fourier infrared spectroscopy were used to identify the components of EZR. We utilized oleic acid-treated HepG2/LO2 cells as in vitro models and zebrafish on high-fat diets (HFD) as animal models, and conducted network pharmacology, RNA sequencing, and biological assays, including confocal fluorescence, commercial kits, western blotting, and quantitative PCR, to investigate the lipid-lowering effect of EZR and its underlying mechanisms.

RESULTS

EZR alleviated lipid accumulation in both in vitro and in vivo models. Analyses through network pharmacology and RNA sequencing revealed that the lipid-lowering properties of EZR were associated with pathways related to lipid biosynthesis, antioxidant functions, and anti-inflammatory mechanisms. Subsequent experimental validation confirmed that EZR decreased the expression levels of FASN, ACC1, HMGCR, ACLY, and LDLR. Additional findings indicated that EZR inhibited mTORC1 activation, leading to the suppression of SREBP1 and SREBP2, thereby mitigating lipid accumulation. Furthermore, EZR was found to downregulate oxidative stress and the levels of inflammatory cytokines.

CONCLUSIONS

EZR demonstrated the ability to lower lipid levels and alleviate HFD-induced MASLD. This is achieved by inhibiting mTORC1/SREBPs-related lipid biosynthesis and reducing oxidative stress and inflammation.

摘要

民族药理学相关性

代谢功能障碍相关脂肪性肝病(MASLD)是全球最普遍的肝脏疾病,主要由不良生活方式选择和饮食习惯引起。竹茹,在中国俗称“竹茹”,是一种来自禾本科竹亚科的传统中药材,常用于肝脏解毒、肝脏保护和降血脂。

研究目的

本研究旨在揭示竹茹提取物(EZR)治疗MASLD的保护作用及其潜在机制。

方法

采用高效液相色谱、液相色谱 - 串联质谱和傅里叶红外光谱法鉴定EZR的成分。我们使用油酸处理的HepG2/LO2细胞作为体外模型,高脂饮食(HFD)喂养的斑马鱼作为动物模型,并进行网络药理学、RNA测序和生物学检测,包括共聚焦荧光、商业试剂盒、蛋白质印迹和定量PCR,以研究EZR的降脂作用及其潜在机制。

结果

EZR在体外和体内模型中均减轻了脂质积累。通过网络药理学和RNA测序分析表明,EZR的降脂特性与脂质生物合成、抗氧化功能和抗炎机制相关的途径有关。随后的实验验证证实,EZR降低了FASN、ACC1、HMGCR、ACLY和LDLR的表达水平。其他研究结果表明,EZR抑制mTORC1激活,导致SREBP1和SREBP2的抑制,从而减轻脂质积累。此外,发现EZR下调氧化应激和炎性细胞因子水平。

结论

EZR具有降低血脂水平和减轻HFD诱导的MASLD的能力。这是通过抑制mTORC1/SREBPs相关的脂质生物合成以及减少氧化应激和炎症来实现的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验